Tralokinumab

4 trials 2 recruiting DDermatology

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

2 Completed trials

2 Sponsors

14 Countries

Phase II/III

Phase II

Phase III/IV

Phase IV

Phase II/III: 1 Phase II: 1 Phase III/IV: 1 Phase IV: 1

Sponsors using this IMP

Leo Pharma A/S 3 Hospital Universitario La Paz 1

All trials

4 total

A phase 3 multi-center trial to evaluate the efficacy and safety of tralokinumab in combination with topical corticosteroids in children (ag… Recruiting

2023-503630-44-00 Phase II/III 12 countries Leo Pharma A/S
Optimization of atopic dermatitis treatment that requires second-line systemic therapy through multiomic predictive models of treatment resp… Recruiting

2023-506165-62-00 Phase IV 1 country Hospital Universitario La Paz
A phase 3b, interventional, adaptive, clinical trial to evaluate the efficacy and safety of tralokinumab 300 mg every second week monotherap… Ended

2022-502653-34-01 Phase III/IV 9 countries LEO PHARMA A/S
Tralokinumab monotherapy for children with moderate-to-severe atopic dermatitis. Ended

2024-512791-36-00 Phase II 4 countries Leo Pharma A/S

Showing 1–4 of 4 trials

← All drugs A–Z